Wang H - Search Results

1

Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC.

Gabrielson A, Wu Y, Wang H, Jiang J, Kallakury B, Gatalica Z, Reddy S, Kleiner D, Fishbein T, Johnson L, Island E, Satoskar R, Banovac F, Jha R, Kachhela J, Feng P, Zhang T, Tesfaye A, Prins P, Loffredo C, Marshall J, Weiner L, Atkins M, He AR. Gabrielson A, et al. Among authors: wang h. Cancer Immunol Res. 2016 May;4(5):419-30. doi: 10.1158/2326-6066.CIR-15-0110. Epub 2016 Mar 11. Cancer Immunol Res. 2016. PMID: 26968206 Free PMC article.

2

Effect of multimodality treatment on overall survival for patients with metastatic or recurrent HPV-positive head and neck squamous cell carcinoma.

Deeken JF, Newkirk K, Harter KW, Marshall MB, Banovac F, Johnson L, Wang H, Wang Y, Zhuang T, Jay AK, Berkowitz F, Esposito G, Kallakury B, Davidson B. Deeken JF, et al. Among authors: wang h, wang y. Head Neck. 2015 May;37(5):630-5. doi: 10.1002/hed.23644. Epub 2014 Apr 30. Head Neck. 2015. PMID: 24616038

3

Maintenance therapy with capecitabine in patients with resected pancreatic adenocarcinoma after adjuvant therapy: a retrospective cohort study.

Weinberg BA, Wang H, Yang X, Wu CS, Pishvaian MJ, He AR, Marshall JL, Hwang JJ. Weinberg BA, et al. Among authors: wang h. Gastrointest Cancer Res. 2014 May;7(3-4):91-7. Gastrointest Cancer Res. 2014. PMID: 25276262 Free PMC article.

4

βII-Spectrin (SPTBN1) suppresses progression of hepatocellular carcinoma and Wnt signaling by regulation of Wnt inhibitor kallistatin.

Zhi X, Lin L, Yang S, Bhuvaneshwar K, Wang H, Gusev Y, Lee MH, Kallakury B, Shivapurkar N, Cahn K, Tian X, Marshall JL, Byers SW, He AR. Zhi X, et al. Among authors: wang h. Hepatology. 2015 Feb;61(2):598-612. doi: 10.1002/hep.27558. Hepatology. 2015. PMID: 25307947 Free PMC article.

5

Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survival.

Tilan JU, Krailo M, Barkauskas DA, Galli S, Mtaweh H, Long J, Wang H, Hawkins K, Lu C, Jeha D, Izycka-Swieszewska E, Lawlor ER, Toretsky JA, Kitlinska JB. Tilan JU, et al. Among authors: wang h. Cancer. 2015 Mar 1;121(5):697-707. doi: 10.1002/cncr.29090. Epub 2014 Nov 11. Cancer. 2015. PMID: 25387699 Free PMC article.

6

A phase 1 study of cetuximab and lapatinib in patients with advanced solid tumor malignancies.

Deeken JF, Wang H, Subramaniam D, He AR, Hwang J, Marshall JL, Urso CE, Wang Y, Ramos C, Steadman K, Pishvaian MJ. Deeken JF, et al. Among authors: wang h, wang y. Cancer. 2015 May 15;121(10):1645-53. doi: 10.1002/cncr.29224. Epub 2015 Jan 29. Cancer. 2015. PMID: 25641763 Free PMC article. Clinical Trial.

7

Strong association between long and heterogeneous telomere length in blood lymphocytes and bladder cancer risk in Egyptian.

Wang H, Wang Y, Kota KK, Kallakury B, Mikhail NN, Sayed D, Mokhtar A, Maximous D, Yassin EH, Gouda I, Sobitan A, Sun B, Loffredo CA, Zheng YL. Wang H, et al. Among authors: wang y. Carcinogenesis. 2015 Nov;36(11):1284-90. doi: 10.1093/carcin/bgv121. Epub 2015 Sep 5. Carcinogenesis. 2015. PMID: 26342126 Free PMC article.

8

Phase II study of temozolomide and veliparib combination therapy for sorafenib-refractory advanced hepatocellular carcinoma.

Gabrielson A, Tesfaye AA, Marshall JL, Pishvaian MJ, Smaglo B, Jha R, Dorsch-Vogel K, Wang H, He AR. Gabrielson A, et al. Among authors: wang h. Cancer Chemother Pharmacol. 2015 Nov;76(5):1073-9. doi: 10.1007/s00280-015-2852-2. Epub 2015 Oct 8. Cancer Chemother Pharmacol. 2015. PMID: 26449224 Free PMC article. Clinical Trial.

9

An endogenous DNA adduct as a prognostic biomarker for hepatocarcinogenesis and its prevention by Theaphenon E in mice.

Fu Y, Silverstein S, McCutcheon JN, Dyba M, Nath RG, Aggarwal M, Coia H, Bai A, Pan J, Jiang J, Kallakury B, Wang H, Zhang YW, Giaccone G, He AR, Chung FL. Fu Y, et al. Among authors: wang h. Hepatology. 2018 Jan;67(1):159-170. doi: 10.1002/hep.29380. Epub 2017 Nov 13. Hepatology. 2018. PMID: 28718980 Free PMC article.

10

Regorafenib in advanced hepatocellular carcinoma (HCC): considerations for treatment.

Kim K, Jha R, Prins PA, Wang H, Chacha M, Hartley ML, He AR. Kim K, et al. Among authors: wang h. Cancer Chemother Pharmacol. 2017 Nov;80(5):945-954. doi: 10.1007/s00280-017-3431-5. Epub 2017 Sep 20. Cancer Chemother Pharmacol. 2017. PMID: 28932966

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

141,423 results

Search Page